Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

539
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
539
Hazard Ratio01:12

Hazard Ratio

115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
115
Biostatistics: Overview01:20

Biostatistics: Overview

238
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
238
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

124
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asymptotic validity of Schoenfeld's sample size formula for the Cox proportional hazards model via the Wald test approach.

Statistical methods in medical research·2026
Same author

Power priors and type I error control: constrained borrowing of external control data.

Journal of biopharmaceutical statistics·2025
Same author

A Note on the Sample Size Formula for a Win Ratio Endpoint.

Statistics in medicine·2025
Same author

A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials.

Trials·2023
Same author

Factors Affecting the Outcome of Medical Treatment in Cats with Obstructive Ureteral Stones Treated with Tamsulosin: 70 Cases (2018-2022).

Veterinary sciences·2022
Same author

Optimization of dose selection using multiple surrogates of toxicity as a continuous variable in phase I cancer trial.

Contemporary clinical trials·2021

Related Experiment Video

Updated: Jun 27, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

499

Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.

Se Yoon Lee1

  • 1Department of Statistics, Texas A &M University, 3143 TAMU, College Station, TX, 77843, USA. seyoonlee.stat.math@gmail.com.

BMC Medical Research Methodology
|May 7, 2024
PubMed
Summary

Bayesian statistics enhances medical science by assessing treatment safety and efficacy, especially with external data. This tutorial reviews its use in clinical trials for regulatory submissions, offering innovative design insights.

Keywords:
Bayesian hypothesis testingFrequentist operating characteristicsRegulatory environmentSample size determination

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

Related Experiment Videos

Last Updated: Jun 27, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

499
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

Area of Science:

  • Medical Statistics
  • Clinical Trial Design
  • Regulatory Science

Background:

  • Bayesian statistics offers advantages over classical methods in medical research, particularly for incorporating prior information from external data sources.
  • The complexity of modern clinical trials often necessitates advanced statistical approaches where frequentist methods may be insufficient.
  • There's a growing trend in regulatory submissions utilizing Bayesian statistics for its flexibility and decision-making insights.

Purpose of the Study:

  • To provide a comprehensive overview of Bayesian statistics in clinical trial design and regulatory submissions.
  • To detail the application of Bayesian methods in key areas such as sample size determination, type I error control, and external data borrowing.
  • To serve as a resource for developing complex and innovative clinical trial designs.

Main Methods:

  • Tutorial review of Bayesian statistical principles and applications in clinical trials.
  • Discussion of frequentist operating characteristics for Bayesian analysis in regulatory contexts.
  • Illustrative examples of Bayesian sample size determination and other methodologies.

Main Results:

  • Bayesian statistics provides a flexible framework for assessing treatment safety and efficacy.
  • The use of Bayesian methods is increasing in regulatory submissions due to their ability to handle complex trial designs and incorporate external data.
  • Consideration of frequentist error rates is crucial for regulatory acceptance of Bayesian strategies.

Conclusions:

  • Bayesian statistics is a vital tool for advancing medical science and improving clinical trial design.
  • Its application in regulatory submissions offers significant advantages for decision-making in complex healthcare scenarios.
  • This review equips researchers and statisticians with foundational knowledge for innovative Bayesian trial designs.